Fig. 2From: Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South AfricaA Methods used for incidence rates of ARI, SARI and deaths in South Africa. B Estimates of RSV-associated ARI and SARI rates per 100,000 person-years in South Africa by age group and medical status. Error bars show 95% CI values. ARI rates shown are before applying the adjustment described in the “Methods” section that aligns the South African ILI rates with the ARI definitionBack to article page